SMTL ID : 1p45.1

Targeting tuberculosis and malaria through inhibition of enoyl reductase: compound activity and structural data

Coordinates

PDB Format

Method

X-RAY DIFFRACTION 2.60 Å

Oligo State

homo-tetramer

Ligands

4 x NAD: NICOTINAMIDE-ADENINE-DINUCLEOTIDE(Non-covalent)(Covalent)

NAD.1: 25 residues within 4Å: Chain A: G.14, I.15, I.16, S.20, I.21, A.22, F.41, L.63, D.64, V.65, S.94, I.95, G.96, F.97, I.122, M.147, D.148, M.161, K.165, A.191, G.192, P.193, I.194, T.196 Ligands: TCL.2 14 PLIP interactions: 14 interactions with chain A Hydrophobic interactions: A:I.21, A:A.191 Hydrogen bonds: A:G.14, A:I.21, A:A.22, A:D.64, A:V.65, A:S.94, A:I.95, A:K.165, A:I.194, A:I.194 Water bridges: A:I.95 pi-Stacking: A:F.41 NAD.4: 24 residues within 4Å: Chain B: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, K.165, A.191, G.192, P.193, I.194, T.196, A.198 Ligands: TCL.5 13 PLIP interactions: 13 interactions with chain B Hydrophobic interactions: B:F.149, B:A.191 Hydrogen bonds: B:G.14, B:S.20, B:I.21, B:D.64, B:D.64, B:V.65, B:I.95, B:K.165, B:I.194, B:I.194, B:T.196 NAD.6: 25 residues within 4Å: Chain C: G.14, I.15, I.16, S.20, I.21, A.22, F.41, L.63, D.64, V.65, S.94, I.95, G.96, F.97, I.122, M.147, D.148, M.161, K.165, A.191, G.192, P.193, I.194, T.196 Ligands: TCL.7 14 PLIP interactions: 14 interactions with chain C Hydrophobic interactions: C:I.21, C:A.191 Hydrogen bonds: C:G.14, C:I.21, C:A.22, C:D.64, C:V.65, C:S.94, C:I.95, C:K.165, C:I.194, C:I.194 Water bridges: C:I.95 pi-Stacking: C:F.41 NAD.9: 24 residues within 4Å: Chain D: G.14, I.15, I.16, S.20, I.21, F.41, L.63, D.64, V.65, S.94, I.95, G.96, I.122, M.147, D.148, F.149, K.165, A.191, G.192, P.193, I.194, T.196, A.198 Ligands: TCL.10 13 PLIP interactions: 13 interactions with chain D Hydrophobic interactions: D:F.149, D:A.191 Hydrogen bonds: D:G.14, D:S.20, D:I.21, D:D.64, D:D.64, D:V.65, D:I.95, D:K.165, D:I.194, D:I.194, D:T.196

6 x TCL: TRICLOSAN(Non-covalent)

TCL.2: 8 residues within 4Å: Chain A: G.96, M.98, M.103, F.149, Y.158, M.199 Ligands: NAD.1, TCL.3 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:Y.158 Hydrogen bonds: A:Y.158 pi-Stacking: A:F.149 Halogen bonds: A:M.98 TCL.3: 12 residues within 4Å: Chain A: Q.100, M.103, G.104, F.149, A.157, Y.158, P.193, M.199, I.202, I.215, L.218 Ligands: TCL.2 4 PLIP interactions: 4 interactions with chain A Hydrophobic interactions: A:F.149, A:Y.158, A:I.215, A:L.218 TCL.5: 11 residues within 4Å: Chain B: G.96, F.97, M.98, M.103, F.149, Y.158, M.161, A.198, M.199, I.202 Ligands: NAD.4 8 PLIP interactions: 8 interactions with chain B Hydrophobic interactions: B:F.149, B:Y.158, B:I.202, B:I.202 Hydrogen bonds: B:Y.158, B:Y.158 pi-Stacking: B:F.149 Halogen bonds: B:M.98 TCL.7: 8 residues within 4Å: Chain C: G.96, M.98, M.103, F.149, Y.158, M.199 Ligands: NAD.6, TCL.8 4 PLIP interactions: 4 interactions with chain C Hydrophobic interactions: C:Y.158 Hydrogen bonds: C:Y.158 pi-Stacking: C:F.149 Halogen bonds: C:M.98 TCL.8: 12 residues within 4Å: Chain C: Q.100, M.103, G.104, F.149, A.157, Y.158, P.193, M.199, I.202, I.215, L.218 Ligands: TCL.7 4 PLIP interactions: 4 interactions with chain C Hydrophobic interactions: C:F.149, C:Y.158, C:I.215, C:L.218 TCL.10: 11 residues within 4Å: Chain D: G.96, F.97, M.98, M.103, F.149, Y.158, M.161, A.198, M.199, I.202 Ligands: NAD.9 8 PLIP interactions: 8 interactions with chain D Hydrophobic interactions: D:F.149, D:Y.158, D:I.202, D:I.202 Hydrogen bonds: D:Y.158, D:Y.158 pi-Stacking: D:F.149 Halogen bonds: D:M.98

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Kuo, M.R. et al., Targeting tuberculosis and malaria through inhibition of Enoyl reductase: compound activity and structural data. J.Biol.Chem. (2003)

Release Date

2003-09-16

Peptides

Enoyl-[acyl-carrier-protein] reductase [NADH]: ABCD

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

B
B

C
A

D
B

Enoyl-[acyl-carrier-protein] reductase [NADH]

Related Entries With Identical Sequence